Casi Pharmaceuticals (CASIF) Stock Price, News & Analysis
Company Description
Casi Pharmaceuticals (OTC Link: CASIF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $2.8M.
CASIF stock has declined 42.4% over the past year. Shares last traded at $0.1533.
On a trailing twelve-month basis, Casi Pharmaceuticals reported revenue of $20.7M with net income of -$48.1M and diluted earnings per share of $-2.59. The company operates at a net profit margin of -232.0%.
This page provides a comprehensive overview of CASIF stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Casi Pharmaceuticals (CASIF) stock last traded at $0.1533, up 9.49% from the previous close. Over the past 12 months, the stock has lost 42.4%. At a market capitalization of $2.8M, CASIF is classified as a micro-cap stock with approximately 20.6M shares outstanding.
CASIF Rankings
Latest News
SEC Filings
Casi Pharmaceuticals has filed 5 recent SEC filings, including 3 Form 6-K, 1 Form 25-NSE, 1 Form SCHEDULE 13D/A. The most recent filing was submitted on July 15, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CASIF SEC filings →
Financial Highlights
Casi Pharmaceuticals generated $20.7M in revenue over the trailing twelve months, retaining a 48.6% gross margin, operating income reached -$45.0M (-217.3% operating margin), and net income was -$48.1M, reflecting a -232.0% net profit margin. Diluted earnings per share stood at $-2.59. The company generated -$20.8M in operating cash flow. With a current ratio of 0.27, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Casi Pharmaceuticals (CASIF) currently stands at 144.5 thousand shares, down 49.0% from the previous reporting period, representing 1.4% of the float. Over the past 12 months, short interest has decreased by 67.9%. This relatively low short interest suggests limited bearish sentiment. With 16.8 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Casi Pharmaceuticals (CASIF) currently stands at 16.8 days, up 218.4% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 1578% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 43.4 days.
CASIF Company Profile & Sector Positioning
Casi Pharmaceuticals (CASIF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.